CPHL Pharmaceuticals: Major
Health Technology
Mkt Cap
17.4B
P/E (TTM)
16.08
EPS
3.90
ROE
13.28%
Div Yield
4.58%
5 years
FY2025FY2024FY2023FY2022FY2021
Profitability
Return on Equity (ROE)10.81%15.15%13.05%14.40%13.15%
Return on Assets (ROA)5.98%7.78%7.27%8.94%7.84%
Return on Invested Capital10.77%15.13%12.71%13.71%12.29%
Gross Margin14.57%12.06%11.63%13.25%12.82%
Operating Margin11.44%8.95%8.81%9.28%9.24%
EBITDA Margin12.72%10.06%9.54%10.07%10.38%
Net Margin6.78%6.72%5.31%6.68%6.07%
Pre-Tax Margin10.30%10.30%7.71%10.84%8.62%
Liquidity
Current Ratio1.301.361.481.862.45
Quick Ratio0.760.780.891.292.03
Leverage
Debt / Equity0.270.250.290.200.15
Debt / Assets0.160.120.160.120.10
LT Debt / Equity0.010.000.000.050.05
LT Debt / Assets0.000.000.000.030.03
Net Debt1.36B763.9K-6.61M-1.03B-2.43B
Total Debt2.94B1.41B1.55B945.78M645.71M
Efficiency
Asset Turnover0.881.161.371.341.29
Inventory Turnover3.123.705.056.816.05
Per Share
Book Value Per Share47.5724.6623.5220.6329.40
Tangible Book Per Share47.5724.6623.5220.6329.40
Cash Per Share6.956.186.808.6918.79
Total Debt Per Share12.896.186.784.173.95
Working Capital Per Share9.488.919.3311.3217.95
Shares & Market
Total Shares Outstanding228,461,200228,461,200228,461,200228,461,200148,499,985
Market Cap19.18B6.51B4.88B7.46B
Enterprise Value20.54B6.51B4.87B6.38B
Employees627615594587573
Shareholders16,45616,45616,45616,45616,456